Skip to main content

Table 3 A comparison of Growth and Clinical Outcomes between Infants Exposed to HIV and Breastfed for a minimum of 6 months or Breastfed for less than 6 months

From: Growth patterns and clinical outcomes in association with breastfeeding duration in HIV exposed and unexposed infants: a cohort study in KwaZulu Natal, South Africa

Infant Growth and Clinical Outcomes

Breastfed > 6 months

Breastfed < 6 months

P Value

Infant Growth, WHO Z scores (median [IQR])

Age 3 months

 WAZ

0.40 (−0.23; 1.03)

−0.80 (− 0.65; 0.82)

0.051

 LAZ

1.02 (− 0.09; 1.96)

0.54 (− 0.41; 1.49)

0.068

 WLZ

−0.13 (−1.31; 0.58)

− 0.43 (−1.22; 0.82)

0.975

Age 6 months

 WAZ

0.32 (−0.17; 1.11)

0.20 (− 0.71; 0.53)

0.147

 LAZ

0.61 (−0.64; 1.69)

0.46 (−0.33; 1.26)

0.878

 WLZ

0.20 (−0.75; 1.06)

0.15 (−0.96; 0.62)

0.229

Age 9 months

 WAZ

0.47 (−0.35; 1.03)

0.29 (−0.62; 0.75)

0.488

 LAZ

0.68 (−0.25; 1.45)

0.85 (−0.14; 1.98)

0.375

 WLZ

0.11 (−0.51; 0.76)

0.09 (−1.08; 0.37)

0.117

Growth Faltering n(%)

Age 3 months

 Underweight

1 (1.32)

1 (2.13)

0.620

 Stunting

3 (3.95)

2 (4.26)

0.635

 Wasting

6 (7.89)

5 (10.64)

0.416

Age 6 months

 Underweight

3 (3.95)

1 (2.17)

0.514

 Stunting

3 (3.95)

2 (4.35)

0.626

 Wasting

4 (5.26)

5 (10.87)

0.212

Age 9 months

 Underweight

1 (1.37)

0

0.624

 Stunting

4 (5.48)

3 (6.82)

0.529

 Wasting

1 (1.37)

1 (2.27)

0.613

Infants with 1 or more episodes n(%)

 Rash/Skin Disease

36 (47.37)

22 (46.81)

0.550

 Fever

0

1 (2.13)

0.382

 URTI

21 (27.63)

16 (34.04)

0.289

 Acute GE

2 (2.63)

4 (8.51)

0.149

 LRTI

1 (1.32)

2 (4.26)

0.325